Drugs / GSCF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05567835 Background | Mar 2024 → Feb 2025 | gastric adenocarcinoma, gastroesophageal junction adenocarcinoma | Baylor College of Medicine | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSCF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05567835 ↗ |